Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast) (Text with EEA relevance)

Type Regulation
Publication 2009-12-22
Last updated 2026-05-18
State In force
Department Council of the European Union, European Parliament
Source EUR-Lex
articles 42
Reform history JSON API
Reference number Substance identification Substance identification Substance identification Substance identification Conditions Conditions Conditions Wording of conditions of use and warnings
Reference number Chemical name/INN/XAN Name of Common Ingredients Glossary CAS number EC number Product type, body parts Maximum concentration in ready for use preparation Other Wording of conditions of use and warnings
a b c d e f g h i
1
2 N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl) anilinium methyl sulfate Camphor Benzalkonium Methosulfate 52793-97-2 258-190-8 6 %
3 Benzoic acid, 2- hydroxy-, 3,3,5- trimethylcyclohexyl ester/Homosalate [^E0098] Homosalate 118-56-9 204-260-8 Face products with the exception of propellent spray products 7,34 %
4 2-Hydroxy-4-methoxy-benzophenone/Oxybenzone [^E0096] Benzophenone-3 131-57-7 205-031-5 a) Face products, hand products, and lip products, excluding propellant and pump spray products b) Body products, including propellant and pump spray products c) Other products a) 6 % b) 2,2 % c) 0,5 % For a) and b) Not more than 0,5 % to protect product formulation a) If used at 0,5 % to protect product formulation, the levels used as UV filter must not exceed 5,5 %. b) If used at 0,5 % to protect product formulation, the levels used as UV filter must not exceed 1,7 %. For a) and b): Contains Benzophenone-3 [^E0091]
5 Moved or deleted Moved or deleted Moved or deleted Moved or deleted Moved or deleted Moved or deleted Moved or deleted Moved or deleted
6 2-Phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts/Ensulizole Phenylbenzimidazole Sulfonic Acid 27503-81-7 248-502-0 8 %(as acid)
7 3,3'-(1,4-Phenylenedimethylene) bis(7, 7-dimethyl-2-oxobicyclo-[2.2.1]hept-1-yl-methanesulfonic acid) and its salts/Ecamsule Terephthalylidene Dicamphor Sulfonic Acid 92761-26-7, 90457-82-2 410-960-6 10 %(as acid)
8 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione/Avobenzone Butyl Methoxydibenzoylmethane 70356-09-1 274-581-6 5 %
9 alpha-(2-Oxoborn-3-ylidene)-toluene-4-sulphonic acid and its salts Benzylidene Camphor Sulfonic Acid 56039-58-8 6 % (as acid)
10 2-Cyano-3,3-diphenyl acrylic acid, 2- ethylhexyl ester/Octocrylene [^E0096] [^E0097] Octocrylene 6197-30-4 228-250-8 a) Propellant spray products b) Other products a) 9 % b) 10 %
11 Polymer of N-{(2 and 4)-[(2-oxoborn-3-ylidene)methyl]benzyl} acrylamide Polyacrylamidomethyl Benzylidene Camphor 113783-61-2 6 %
12 2-Ethylhexyl 4-methoxycinnamate/Octinoxate Ethylhexyl Methoxycinnamate 5466-77-3 226-775-7 10 %
13 Ethoxylated ethyl-4-aminobenzoate PEG-25 PABA 116242-27-4 10 %
14 Isopentyl-4-methoxycinnamate/Amiloxate Isoamyl p-Methoxycinnamate 71617-10-2 275-702-5 10 %
15 2,4,6-Trianilino-(p-carbo-2'-ethylhexyl-1'-oxy)-1,3,5-triazine Ethylhexyl Triazone 88122-99-0 402-070-1 5 %
16 Phenol,2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3-(1,3,3,3-tetramethyl-1-(trimethylsilyl)oxy)-disiloxanyl)propyl) Drometrizole Trisiloxane 155633-54-8 15 %
17 Benzoic acid, 4,4-((6-((4-(((1,1-dimethylethyl)amino)carbonyl)phenyl)amino)-1,3,5-triazine-2,4-diyl)diimino)bis-, bis (2-ethylhexyl) ester/Iscotrizinol (USAN) Diethylhexyl Butamido Triazone 154702-15-5 10 %
————— ————— ————— ————— ————— ————— ————— ————— —————
————— ————— ————— ————— ————— ————— ————— ————— —————
20 2-Ethylhexyl salicylate/Octisalate Ethylhexyl Salicylate 118-60-5 204-263-4 5 %
21 2-Ethylhexyl 4-(dimethylamino)benzoate/Padimate O (USAN:BAN) Ethylhexyl Dimethyl PABA 21245-02-3 244-289-3 8 %
22 2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt/Sulisobenzone Benzophenone-4, Benzophenone-5 4065-45-6/6628-37-1 223-772-2 / - 5 % (as acid)
23 2,2′-Methylene- bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)/Bisoctrizole Methylene Bis-Benzotriazolyl Tetramethylbutylphenol 103597-45-1 403-800-1 10 % [^E0095]
23a 2,2′-Methylene- bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)/Bisoctrizole Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano) 103597-45-1 403-800-1 10 % [^E0095] Not to be used in applications that may lead to exposure of the end user's lungs by inhalation. Only nanomaterials having the following characteristics are allowed: — Purity ≥ 98,5 %, with 2,2′-methylene-bis-(6(2H-benzotriazol-2-yl)-4-(isooctyl)phenol) isomer fraction not exceeding 1,5 %; — Solubility < 5 ng/L in water at 25 °C; — Partition coefficient (Log Pow): 12,7 at 25 °C; — Uncoated; — Median particle size D50 (50 % of the number below this diameter): ≥ 120 nm of mass distribution and/or ≥ 60 nm of number size distribution.
24 Sodium salt of 2,2'-bis(1,4-phenylene)-1H-benzimidazole-4,6-disulfonic acid) / Bisdisulizole disodium (USAN) Disodium Phenyl Dibenzimidazole Tetrasulfonate 180898-37-7 429-750-0 10 % (as acid)
25 2,2'-(6-(4-Methoxyphenyl)-1,3,5-triazine-2,4-diyl)bis(5-((2-ethylhexyl)oxy)phenol) / Bemotrizinol Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine 187393-00-6 10 %
26 Dimethicodiethylbenzalmalonate Polysilicone-15 207574-74-1 426-000-4 10 %
27 Titanium dioxide [^E0092] Titanium Dioxide 13463-67-7/1317-70-0/1317-80-2 236-675-5/215-280-1/215-282-2 25 % [^E0094] Titanium dioxide in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm, to be used in compliance with Annex III, No 321. For the product types under letter (c) of column (f) in Annex III, No 321, the maximum concentration in ready for use preparation provided in column (g) of this entry applies.
27a Titanium dioxide [^E0092] Titanium Dioxide (nano) 13463-67-7/1317-70-0/1317-80-2 236-675-5/215-280-1/215-282-2 25 % [^E0094] Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. Only nanomaterials having the following characteristics are allowed: — purity ≥ 99 %, — rutile form, or rutile with up to 5 % anatase, with crystalline structure and physical appearance as clusters of spherical, needle, or lanceolate shapes, — median particle size based on number size distribution ≥ 30 nm, — aspect ratio from 1 to 4,5, and volume specific surface area ≤ 460 m2/cm3, — coated with Silica, Hydrated Silica, Alumina, Aluminium Hydroxide, Aluminium Stearate, Stearic Acid, Trimethoxycaprylylsilane, Glycerin, Dimethicone, Hydrogen Dimethicone, Simethicone, or coated with one of the following combinations: — Silica at a maximum concentration of 16 % and Cetyl Phosphate at a maximum concentration of 6 %, — Alumina at a maximum concentration of 7 % and Manganese Dioxide at a maximum concentration of 0,7 % (not to be used in lip products), — Alumina at a maximum concentration of 3 % and Triethoxycaprylylsilane at a maximum concentration of 9 %, — photocatalytic activity ≤ 10 % compared to corresponding non-coated or non-doped reference, — nanoparticles are photostable in the final formulation. For face products containing Titanium Dioxide (nano) coated with the combination Alumina and Manganese Dioxide: Not to be used on the lips.
28 Benzoic acid, 2-[4-(diethylamino)-2- hydroxybenzoyl]-, hexyl ester [^E0100] Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) 302776-68-7 443-860-6 10 % Di-n-hexyl phthalate (DnHexP) as an unavoidable trace impurity in DHHB must not exceed 10 ppm.
29 1,3,5-Triazine, 2,4,6-tris[1,1'-biphenyl]-4-yl-, including as nanomaterial Tris-biphenyl triazine Tris-biphenyl triazine (nano) 31274-51-8 — 10 % Not to be used in sprays. Only nanomaterials having the following characteristics are allowed: — median primary particle size > 80 nm; — Purity ≥ 98 %; — Uncoated
30 Zinc oxide Zinc Oxide 1314-13-2 215-222-5 25 % [^E0093] Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation.
30a Zinc oxide Zinc Oxide (nano) 1314-13-2 215-222-5 25 % [^E0093] Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation. Only nanomaterials having the following characteristics are allowed: — purity ≥ 96 %, with wurtzite crystalline structure and physical appearance as clusters that are rod-like, star-like and/or isometric shapes, with impurities consisting only of carbon dioxide and water, whilst any other impurities are less than 1 % in total, — median diameter of the particle number size distribution D50 (50 % of the number below this diameter) > 30 nm and D1 (1 % below this size) > 20 nm, — water solubility < 50 mg/L — uncoated, or coated with triethoxycaprylylsilane, dimethicone, dimethoxydiphenylsilanetriethoxycaprylylsilane cross-polymer, or octyl triethoxy silane.
31 3,3′-(1,4-Phenylene)bis(5,6-diphenyl-1,2,4-triazine) Phenylene Bis-Diphenyltriazine 55514-22-2 700-823-1 5 % Not to be used in applications that may lead to exposure of the end user's lungs by inhalation.
32 2-ethoxyethyl (2Z)-2-cyano-2-[3-(3-methoxypropylamino) cyclohex-2-en-1-ylidene]acetate Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate 1419401-88-9 700-860-3 3 % — Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation — Do not use with nitrosating agents – Maximum nitrosamine content: 50 μg/kg — Keep in nitrite-free containers
33 1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine 919803-06-8 485-100-6 10 % [^E0099]
34 1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano) 919803-06-8 485-100-6 10 % [^E0099] Only nanomaterials having the following characteristics are allowed: — Purity ≥ 97 % — Median particle size D50 (50 % of the number below this diameter): ≥ 50 nm of number size distribution. Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation.

Not required if concentration is 0,5 % or less and when it is used only for product protection purposes.

For use as a colorant, see Annex IV, No 143.

In case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit given in column g.

In case of combined use of Titanium Dioxide and Titanium Dioxide (nano), the sum shall not exceed the limit given in column g.

In case of combined use of Methylene Bis-Benzotriazolyl Tetramethylbutylphenol and Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano), the sum shall not exceed the limit given in column g.

However, cosmetic products containing that substance and complying with the restrictions set out in Regulation (EC) No 1223/2009 as applicable on 27 July 2022 may be placed on the Union market until 28 January 2023 and be made available on the Union market until 28 July 2023.

Benzophenone as an impurity and/or degradation product of Octocrylene shall be kept at trace level.

[^E0098]: (8)

From 1 January 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 July 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.

In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %.

[^E0100]: (10)

From 1 January 2027 cosmetic products containing ‘Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-, hexyl ester’ and not complying with the conditions shall not be placed on the Union market. From 1 July 2028 cosmetic products containing ‘Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-, hexyl ester’ and not complying with the conditions shall not be made available on the Union market.

ANNEX VII

SYMBOLS USED ON PACKAGING/CONTAINER

1.

Reference to enclosed or attached information

2.

Period-after-opening

3.

Date of minimum durability

Image omitted; see official source

ANNEX VIII

LIST OF VALIDATED ALTERNATIVE METHODS TO ANIMAL TESTING

This Annex lists the alternative methods validated by the European Centre on Validation of Alternative Methods (ECVAM) of the Joint Research Centre available to meet the requirements of this Regulation and which are not listed in Commission Regulation (EC) No 440/2008 of 30 May 2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). As animal testing may not be replaced completely by an alternative method, it should be mentioned in Annex VIII whether the alternative method fully or partially replaces animal testing.

| Reference number | Validated alternative methods | Nature of replacement full or partial |

| --- | --- | --- | | A | B | C |

ANNEX IX

PART A

Repealed Directive with its successive amendments

(referred to in Article 33)

Council Directive 76/768/EEC of 27 July 1976 (OJ L 262, 27.9.1976, p. 169)
Council Directive 79/661/EEC of 24 July 1979 (OJ L 192, 31.7.1979, p. 35)
Commission Directive 82/147/EEC of 11 February 1982 (OJ L 63, 6.3.1982, p. 26)
Council Directive 82/368/EEC of 17 May 1982 (OJ L 167, 15.6.1982, p. 1)
Commission Directive 83/191/EEC of 30 March 1983 (OJ L 109, 26.4.1983, p. 25)
Commission Directive 83/341/EEC of 29 June 1983 (OJ L 188, 13.7.1983, p. 15)
Commission Directive 83/496/EEC of 22 September 1983 (OJ L 275, 8.10.1983, p. 20)
Council Directive 83/574/EEC of 26 October 1983 (OJ L 332, 28.11.1983, p. 38)
Commission Directive 84/415/EEC of 18 July 1984 (OJ L 228, 25.8.1984, p. 31)
Commission Directive 85/391/EEC of 16 July 1985 (OJ L 224, 22.8.1985, p. 40)
Commission Directive 86/179/EEC of 28 February 1986 (OJ L 138, 24.5.1986, p. 40)
Commission Directive 86/199/EEC of 26 March 1986 (OJ L 149, 3.6.1986, p. 38)
Commission Directive 87/137/EEC of 2 February 1987 (OJ L 56, 26.2.1987, p. 20)
Commission Directive 88/233/EEC of 2 March 1988 (OJ L 105, 26.4.1988, p. 11)
Council Directive 88/667/EEC of 21 December 1988 (OJ L 382, 31.12.1988, p. 46)
Commission Directive 89/174/EEC of 21 February 1989 (OJ L 64, 8.3.1989, p. 10)
Council Directive 89/679/EEC of 21 December 1989 (OJ L 398, 30.12.1989, p. 25)
Commission Directive 90/121/EEC of 20 February 1990 (OJ L 71, 17.3.1990, p. 40)
Commission Directive 91/184/EEC of 12 March 1991 (OJ L 91, 12.4.1991, p. 59)
Commission Directive 92/8/EEC of 18 February 1992 (OJ L 70, 17.3.1992, p. 23)
Commission Directive 92/86/EEC of 21 October 1992 (OJ L 325, 11.11.1992, p. 18)
Council Directive 93/35/EEC of 14 June 1993 (OJ L 151, 23.6.1993, p. 32)
Commission Directive 93/47/EEC of 22 June 1993 (OJ L 203, 13.8.1993, p. 24)
Commission Directive 94/32/EC of 29 June 1994 (OJ L 181, 15.7.1994, p. 31)
Commission Directive 95/17/EC of 19 June 1995 (OJ L 140, 23.6.1995, p. 26)
Commission Directive 95/34/EC of 10 July 1995 (OJ L 167, 18.7.1995, p. 19)
Commission Directive 96/41/EC of 25 June 1996 (OJ L 198, 8.8.1996, p. 36)
Commission Directive 97/1/EC of 10 January 1997 (OJ L 16, 18.1.1997, p. 85)
Commission Directive 97/18/EC of 17 April 1997 (OJ L 114, 1.5.1997, p. 43)
Commission Directive 97/45/EC of 14 July 1997 (OJ L 196, 24.7.1997, p. 77)
Commission Directive 98/16/EC of 5 March 1998 (OJ L 77, 14.3.1998, p. 44)
Commission Directive 98/62/EC of 3 September 1998 (OJ L 253, 15.9.1998, p. 20)
Commission Directive 2000/6/EC of 29 February 2000 (OJ L 56, 1.3.2000, p. 42)
Commission Directive 2000/11/EC of 10 March 2000 (OJ L 65, 14.3.2000, p. 22)
Commission Directive 2000/41/EC of 19 June 2000 (OJ L 145, 20.6.2000, p. 25)
Commission Directive 2002/34/EC of 15 April 2002 (OJ L 102, 18.4.2002, p. 19)
Commission Directive 2003/1/EC of 6 January 2003 (OJ L 5, 10.1.2003, p. 14)
Commission Directive 2003/16/EC of 19 February 2003 (OJ L 46, 20.2.2003, p. 24)
Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 (OJ L 66, 11.3.2003, p. 26)
Commission Directive 2003/80/EC of 5 September 2003 (OJ L 224, 6.9.2003, p. 27)
Commission Directive 2003/83/EC of 24 September 2003 (OJ L 238, 25.9.2003, p. 23)
Commission Directive 2004/87/EC of 7 September 2004 (OJ L 287, 8.9.2004, p. 4)
Commission Directive 2004/88/EC of 7 September 2004 (OJ L 287, 8.9.2004, p. 5)
Commission Directive 2004/94/EC of 15 September 2004 (OJ L 294, 17.9.2004, p. 28)
Commission Directive 2004/93/EC of 21 September 2004 (OJ L 300, 25.9.2004, p. 13)
Commission Directive 2005/9/EC of 28 January 2005 (OJ L 27, 29.1.2005, p. 46)
Commission Directive 2005/42/EC of 20 June 2005 (OJ L 158, 21.6.2005, p. 17)
Commission Directive 2005/52/EC of 9 September 2005 (OJ L 234, 10.9.2005, p. 9)
Commission Directive 2005/80/EC of 21 November 2005 (OJ L 303, 22.11.2005, p. 32)
Commission Directive 2006/65/EC of 19 July 2006 (OJ L 198, 20.7.2006, p. 11)
Commission Directive 2006/78/EC of 29 September 2006 (OJ L 271, 30.9.2006, p. 56)
Commission Directive 2007/1/EC of 29 January 2007 (OJ L 25, 1.2.2007, p. 9)
Commission Directive 2007/17/EC of 22 March 2007 (OJ L 82, 23.3.2007, p. 27)
Commission Directive 2007/22/EC of 17 April 2007 (OJ L 101, 18.4.2007, p. 11)
Commission Directive 2007/53/EC of 29 August 2007 (OJ L 226, 30.8.2007, p. 19)
Commission Directive 2007/54/EC of 29 August 2007 (OJ L 226, 30.8.2007, p. 21)
Commission Directive 2007/67/EC of 22 November 2007 (OJ L 305, 23.11.2007, p. 22)
Commission Directive 2008/14/EC of 15 February 2008 OJ L 42, 16.2.2008, p. 43
Commission Directive 2008/42/EC of 3 April 2008 OJ L 93, 4.4.2008, p. 13
Commission Directive 2008/88/EC of 23 September 2008 OJ L 256, 24.9.2008, p. 12
Commission Directive 2008/123/EC of 18 December 2008 OJ L 340, 19.12.2008, p. 71
Commission Directive 2009/6/EC of 4 February 2009 OJ L 36, 5.2.2009, p. 15
Commission Directive 2009/36/EC of 16 April 2009 OJ L 98, 17.4.2009, p. 31

PART B

List of time-limits for transposition into national law and application

(referred to in Article 33)

Directive Time-limit for transposition
Council Directive 76/768/EEC of 27 July 1976 30.1.1978
Council Directive 79/661/EEC of 24 July 1979 30.7.1979
Commission Directive 82/147/EEC of 11 February 1982 31.12.1982
Council Directive 82/368/EEC of 17 May 1982 31.12.1983
Commission Directive 83/191/EEC of 30 March 1983 31.12.1984
Commission Directive 83/341/EEC of 29 June 1983 31.12.1984
Commission Directive 83/496/EEC of 22 September 1983 31.12.1984
Council Directive 83/574/EEC of 26 October 1983 31.12.1984
Commission Directive 84/415/EEC of 18 July 1984 31.12.1985
Commission Directive 85/391/EEC of 16 July 1985 31.12.1986
Commission Directive 86/179/EEC of 28 February 1986 31.12.1986
Commission Directive 86/199/EEC of 26 March 1986 31.12.1986
Commission Directive 87/137/EEC of 2 February 1987 31.12.1987
Commission Directive 88/233/EEC of 2 March 1988 30.9.1988
Council Directive 88/667/EEC of 21 December 1988 31.12.1993
Commission Directive 89/174/EEC of 21 February 1989 31.12.1989
Council Directive 89/679/EEC of 21 December 1989 3.1.1990
Commission Directive 90/121/EEC of 20 February 1990 31.12.1990
Commission Directive 91/184/EEC of 12 March 1991 31.12.1991
Commission Directive 92/8/EEC of 18 February 1992 31.12.1992
Commission Directive 92/86/EEC of 21 October 1992 30.6.1993
Council Directive 93/35/EEC of 14 June 1993 14.6.1995
Commission Directive 93/47/EEC of 22 June 1993 30.6.1994
Commission Directive 94/32/EC of 29 June 1994 30.6.1995
Commission Directive 95/17/EC of 19 June 1995 30.11.1995
Commission Directive 95/34/EC of 10 July 1995 30.6.1996
Commission Directive 96/41/EC of 25 June 1996 30.6.1997
Commission Directive 97/1/EC of 10 January 1997 30.6.1997
Commission Directive 97/18/EC of 17 April 1997 31.12.1997
Commission Directive 97/45/EC of 14 July 1997 30.6.1998
Commission Directive 98/16/EC of 5 March 1998 1.4.1998
Commission Directive 98/62/EC of 3 September 1998 30.6.1999
Commission Directive 2000/6/EC of 29 February 2000 1.7.2000
Commission Directive 2000/11/EC of 10 March 2000 1.6.2000
Commission Directive 2000/41/EC of 19 June 2000 29.6.2000
Commission Directive 2002/34/EC of 15 April 2002 15.4.2003
Commission Directive 2003/1/EC of 6 January 2003 15.4.2003
Commission Directive 2003/16/EC of 19 February 2003 28.2.2003
Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 10.9.2004
Commission Directive 2003/80/EC of 5 September 2003 11.9.2004
Commission Directive 2003/83/EC of 24 September 2003 23.9.2004
Commission Directive 2004/87/EC of 7 September 2004 1.10.2004
Commission Directive 2004/88/EC of 7 September 2004 1.10.2004
Commission Directive 2004/94/EC of 15 September 2004 21.9.2004
Commission Directive 2004/93/EC of 21 September 2004 30.9.2004
Commission Directive 2005/9/EC of 28 January 2005 16.2.2006
Commission Directive 2005/42/EC of 20 June 2005 31.12.2005
Commission Directive 2005/52/EC of 9 September 2005 1.1.2006
Commission Directive 2005/80/EC of 21 November 2005 22.5.2006
Commission Directive 2006/65/EC of 19 July 2006 1.9.2006
Commission Directive 2006/78/EC of 29 September 2006 30.3.2007
Commission Directive 2007/1/EC of 29 January 2007 21.8.2007
Commission Directive 2007/17/EC of 22 March 2007 23.9.2007
Commission Directive 2007/22/EC of 17 April 2007 18.1.2008
Commission Directive 2007/53/EC of 29 August 2007 19.4.2008
Commission Directive 2007/54/EC of 29 August 2007 18.3.2008
Commission Directive 2007/67/EC of 22 November 2007 31.12.2007
Commission Directive 2008/14/EC of 15 February 2008 16.8.2008
Commission Directive 2008/42/EC of 3 April 2008 4.10.2008
Commission Directive 2008/88/EC of 23 September 2008 14.2.2009
Commission Directive 2008/123/EC of 18 December 2008 8.7.2009
Commission Directive 2009/6/EC of 4 February 2009 5.8.2009
Commission Directive 2009/36/EC of 16 April 2009 15.11.2009

ANNEX X

CORRELATION TABLE

Directive 76/768/EEC This Regulation
Article 1 Article 2(1)(a)
Article 2 Article 3
Article 3 —
Article 4(1) Article 14(1)
Article 4(2) Article 17
Article 4a Article 18
Article 4b Article 15(1)
Article 5 —
Article 5a Article 33
Article 6(1),(2) Article 19(1),(2),(3),(4)
Article 6(3) Article 20
Article 7(1) Article 9
Article 7(2) Article 19(5), (6)
Article 7(3) Article 13
Article 7a (1) (h) Article 21
Article 7a(1),(2),(3) Article 10, 11, Annex I
Article 7a(4) Article 13
Article 7a(5) Article 29, 34
Article 8(1) Article 12
Article 8(2) Article 31
Article 8a —
Article 9 Article 35
Article 10 Article 32
Article 11 —
Article 12 Article 27
Article 13 Article 28
Article 14 —
Article 15 —
Annex I Preamble, No. 7
Annex II Annex II
Annex III Annex III
Annex IV Annex IV
Annex V —
Annex VI Annex V
Annex VII Annex VI
Annex VIII Annex VII
Annex VIIIa Annex VII
Annex IX Annex VIII
— Annex IX
— Annex X

[^E0001]: OJ L 204, 21.7.1998, p. 37.

[^E0002]: OJ L 31, 1.2.2002, p. 1.

[^E0003]: OJ L 142, 31.5.2008, p. 1.

[^E0004]: OJ L 11, 15.1.2002, p. 4.

[^E0005]: OJ L 218, 13.8.2008, p. 30.

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.